(Q41519933)

2 October 2017

1 reference

title

Prognostic markers in resectable non-small cell lung cancer (English)

1 reference

2 October 2017

Strauss GM

1

1 reference

2 October 2017

publication date

1 June 1997

1 reference

Hematology / Oncology Clinics of North America

2 October 2017

published in

1 reference

2 October 2017

volume

11

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

409-434

1 reference

DNA content in correlation with postsurgical stage in non-small cell lung cancer

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Screening for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

SYMPTOMATIC PATTERNS, BIOLOGIC BEHAVIOR, AND PROGNOSIS IN CANCER OF THE LUNG. PRACTICAL APPLICATION OF BOOLEAN ALGEBRA AND CLINICAL TAXONOMY.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: have we made progress?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

The effect of surgical treatment on survival from early lung cancer. Implications for screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of the expression ofras oncogene product in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Long-term survival of patients with lung cancer from a defined geographical area before and after radiological screening

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Survival after resection of stage II non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

The relationship of p53 immunostaining to survival in carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

A flow cytometric study of non-small cell lung cancer classified as T1N0

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Limitation of annual screening chest radiography for the diagnosis of lung cancer. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Screening for lung cancer. Another look; a different view

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

Ploidy as a prognostic determinant in surgically treated lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970441-X

7 January 2021

10.1016/S0889-8588(05)70441-X

Identifiers

DOI

1 reference

2 October 2017

1 reference